Evidence map›Paper›PMID 39598444›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Antonio Canoyra, Carmen Martín-Cordero, Dolores Muñoz-Mingarro, Antonio J León-González, Richard B Parsons, Nuria Acero

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Triacylglycerol Composition of Seed Oil fromMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonio CanoyraPharmaceutical and Health Science Department, Pharmacy Faculty, San Pablo-CEU University, CEU Universities, Urbanización Montepríncipe Boadilla del Monte, 28660 Madrid, Spain.
Carmen Martín-CorderoDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, C/P. García González, 2, 41012 Seville, Spain.ORCID 0000-0002-2821-6327
Dolores Muñoz-MingarroChemistry and Biochemistry Department, Pharmacy Faculty, San Pablo-CEU University, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28668 Madrid, Spain.
Antonio J León-GonzálezDepartment of Pharmacology, Faculty of Pharmacy, University of Seville, C/P. García González, 2, 41012 Seville, Spain.ORCID 0000-0003-2668-8205
Richard B ParsonsKing's College London, Institute of Pharmaceutical Sciences, 150 Stamford Street, London SE1 9NH, UK.
Nuria AceroPharmaceutical and Health Science Department, Pharmacy Faculty, San Pablo-CEU University, CEU Universities, Urbanización Montepríncipe Boadilla del Monte, 28660 Madrid, Spain.ORCID 0000-0001-9307-3839

Funding

Fundación Universitaria San Pablo CEU. MBERRYNAProject PLEC2022-009299, funded by MCIN/AEI/10.13039/501100011033 and the Euro-pean Union «NextGenerationEU/PRTR PLEC2022-009299, MCIN/AEI/10.13039/501100011033.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseberriesCorema albumneuroprotectiveoxidative stressParkinson’s diseasephenols

Identifiers

PMID39598444
PMCPMC11597836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.